Cme Group Inc. · NASDAQ:CME

Cme — Q3 2020 Earnings Presentation

7 slides from Cme's earnings presentation, Oct 28, 2020

  1. Slide 1: 3Q 2020 Summary

    3Q 2020 Earnings Commentary Revenue Adjusted Adjusted Expense* Diluted EPS 3Q 2020 Summary in millions • Despite the many challenges created by the ongoing pandemic, CME Group $1,400 $2.00 continues to help clients manage their risk and navigate uncertainty. CME Legacy Group’s highly diverse product

  2. Slide 2: 3Q 2020 Highlights

    3Q 2020 Earnings Commentary - Unaudited 3Q 2020 Highlights CME Group’s highly diverse product set positions the company well for varying macroeconomic backdrops Significant strength across Equity Index products FX 3Q20 ADV up 14% sequentially from 2Q20 • 3Q20 Equity Index ADV grew 38% to 5.4 million

  3. Slide 3: YTD 2020 non-U.S. ADV grew 8% to 5.5 million contracts

    3Q 2020 Earnings Commentary - Unaudited YTD 2020 non-U.S. ADV grew 8% to 5.5 million contracts, with growth across Equities, FX, Agricultural Commodities and Metals 3.0 Non-U.S. ADV by Product Line • YTD 2020 non-U.S. ADV highlights: ADV in millions • Equity Index ADV grew 88% to 1.5 million contrac

  4. Slide 4: Capital efficiencies from Gold warrant collateral program now total over $3 billion

    3Q 2020 Earnings Commentary - Unaudited Capital efficiencies from Gold warrant collateral program now total a record of over $3 billion • Approximately one year ago, in response to customer inquiries, CME Group began accepting COMEX gold warrants as collateral from clearing members to meet Base and

  5. Slide 5: 3Q 2020 Product Detail - Financials and Commodities

    3Q 2020 Earnings Commentary - Unaudited Prepared for 4Q20 BrokerTec migration to CME Globex, as the first step in providing enhanced market access and functionality for fixed income traders • The BrokerTec Global Front End (GFE) will maintain its current look, feel and functionality once integrated,

  6. Slide 6: Financial Results

    3Q 2020 Earnings Commentary - Unaudited Dividends Paid* $ in millions Financial Results $2,500 • 3Q20 revenue was $1.1 billion Regular Quarterly • 3Q20 clearing and transaction fees revenue totaled $835 Dividend million, including approximately $106 million from cash Annual Variable $2,000 markets a

  7. Slide 7: Use of Non-GAAP Measures and Forward-Looking Statements

    3Q 2020 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation mate

CME Group — Q3 2020 Earnings Presentation on 6ix